Connect with us

Health

Rare ‘No-Burp Syndrome’ Gains Attention, But Treatment Remains Costly

Published

on

A rare condition known as retrograde cricopharyngeal dysfunction (R-CPD), or “no-burp syndrome,” is gaining attention on social media, with medical specialists and affected individuals raising awareness about its impact. Despite growing recognition, treatment options remain expensive and largely inaccessible.

For many individuals, burping is a routine bodily function, but for those with R-CPD, it is impossible. The condition, formally identified in 2019 by Dr. Robert Bastian of the Bastian Voice Institute, prevents the cricopharyngeus muscle in the upper esophagus from relaxing, trapping air in the digestive system. This results in painful bloating, gurgling sounds in the throat, and severe discomfort.

Dulcie, a 23-year-old research student from the UK, experienced these symptoms for years without understanding the cause. “Now I know what R-CPD is, I blame it for many of the barriers to generally good physical and mental health that I face,” she told Euronews Health. She also links her severe phobia of vomiting to the condition, as the pressure buildup in her chest sometimes induces nausea.

Despite increasing awareness, R-CPD remains largely unrecognized by healthcare professionals. “There is a treatment for the condition, but it is not NHS-approved yet because many doctors are unaware of it or don’t consider it a health issue,” said Mr. Yakubu Karagama, a laryngologist at Guy’s and St Thomas’ NHS Foundation Trust. He argues that the condition is often dismissed as a social issue rather than a legitimate medical concern.

The Challenges of Diagnosis and Treatment

Diagnosing R-CPD typically requires an endoscopy, but few doctors specialize in the condition. The most effective treatment currently available is botulinum toxin (Botox) injections into the cricopharyngeus muscle, which helps relax the muscle and allow burping. However, the treatment is costly—upwards of £3,000 (€3,621) through private healthcare in the UK—and is not widely covered by insurance due to the condition’s relatively recent recognition.

See also  Europe Gears Up for Marathon Season as Runners Take to the Streets

A recent study by Texas-based researchers found that individuals with R-CPD were more likely to struggle with anxiety, depression, and social embarrassment, impacting their professional and personal lives. “Sitting up at my desk for full days is actively painful,” Dulcie said. “I can’t do anything in the evenings because I have to lie down for the gurgles and pain to subside.”

For Amelia, a 41-year-old who was formally diagnosed with R-CPD, the condition severely impacted her social life. “I couldn’t drink with my food, couldn’t enjoy nights out or meals out. It was embarrassing, painful, and socially debilitating,” she said. After receiving Botox treatment six years ago at a cost of £5,000 (€6,038), she described it as “the best money I’ve ever spent.”

Alternative Approaches and Hope for the Future

While Botox treatment is effective in about 90% of cases, the procedure carries risks, including temporary acid reflux and swallowing difficulties. Some patients have reported success with alternative methods, such as physical exercises targeting the neck and throat muscles.

Dr. Lee Akst, a laryngologist at Johns Hopkins Medicine, suggests head posture exercises may encourage burping. However, he acknowledges that success rates are anecdotal, with no standardized regimen available.

For now, many individuals suffering from R-CPD continue to push for greater medical recognition and accessibility to treatment. “If this works, it will change my life,” said Dulcie, who is scheduled for treatment soon. “I’ll be able to eat a full meal out with friends without retreating home in discomfort.”

As awareness grows, there is hope that increased research and recognition will lead to broader medical acknowledgment and more affordable treatment options for those living with no-burp syndrome.

Health

AI Model Surpasses Doctors in Key Medical Decision Tests, Study Finds

Published

on

A new study by researchers at Harvard Medical School and Beth Israel Deaconess Medical Center has found that advanced artificial intelligence systems can outperform human doctors in several medical reasoning tasks, including diagnosis and emergency care decisions.

The research compared physicians with large language models across a range of clinical scenarios. According to the findings, AI systems showed stronger performance in tasks such as identifying likely diagnoses, recommending treatment steps, and making decisions in emergency department settings where information is often limited.

Arjun Manrai, a co-senior author of the study, said the results demonstrate the rapid progress of AI in healthcare. He noted that the model surpassed both earlier systems and physician benchmarks in most tests. At the same time, he cautioned that better performance in controlled settings does not guarantee improved outcomes in real-world care.

The study evaluated OpenAI’s reasoning model, released in 2024, using a mix of published clinical cases and real-world emergency department data. Researchers presented the system with patient scenarios at different stages of care, from initial triage to later admission decisions. At each step, the AI was given only the information available at that point and asked to suggest diagnoses and next actions.

The results showed that the AI consistently outperformed doctors, especially in areas requiring structured reasoning and documentation. The largest gap appeared during the triage stage, when limited information makes decision-making more difficult. As additional data became available, both AI and physicians improved in accuracy, though the AI maintained an edge in many cases.

Peter Brodeur, a co-author of the study, said traditional testing methods such as multiple-choice questions are no longer sufficient to measure progress, as many AI models now achieve near-perfect scores. He added that newer evaluation approaches are needed to track further advances.

See also  Study Finds Sharp Rise in Depression and Psychosis Risk After Childbirth

Despite the promising results, researchers stressed that the use of AI in healthcare must be approached carefully. They warned that while a model may correctly identify a diagnosis, it could also recommend unnecessary tests or interventions that might carry risks for patients.

The study’s authors called for further trials in real clinical environments to better understand how AI tools perform in practice. They also highlighted the need for investment in infrastructure and clear frameworks to support the safe use of such technologies.

The findings come with some limitations, as the analysis focused on a specific version of the AI model, which has since been updated. Researchers said additional studies are needed to compare different systems and explore how doctors and AI can work together effectively in patient care.

Continue Reading

Health

New Study Reveals How Coffee May Help Protect the Body From Ageing

Published

on

A new study has uncovered a key biological mechanism that may explain why coffee has long been linked to healthier ageing and a lower risk of chronic disease.

Researchers at Texas A&M College of Veterinary Medicine & Biomedical Sciences found that compounds in coffee interact with a protein in the body known as NR4A1, a receptor involved in regulating stress responses, inflammation and cellular repair. The findings shed new light on how coffee may help protect the body from age-related decline.

For years, studies have associated regular coffee consumption with a longer life and reduced risk of conditions such as heart disease, cancer and cognitive decline. Until now, however, the biological processes behind those benefits have remained largely unclear.

The research team identified NR4A1 as a critical target for several naturally occurring compounds in coffee, particularly polyphenols and other polyhydroxylated substances. These compounds bind to the receptor and appear to influence how it functions.

NR4A1 acts as what scientists call a nutrient sensor, responding to dietary compounds and helping the body adapt to stress and damage. It plays an important role in controlling inflammation, maintaining energy balance and promoting tissue repair — all essential processes in healthy ageing.

Stephen Safe, one of the study’s lead researchers, said the findings provide a clearer understanding of coffee’s protective effects. He explained that NR4A1 helps limit damage when tissues are under stress, and that its absence can worsen the effects of injury or disease.

Laboratory tests showed that coffee compounds reduced cellular damage and slowed the growth of cancer cells. When researchers removed NR4A1 from the cells, those benefits disappeared, strongly suggesting that the receptor is central to coffee’s protective action.

See also  Health Experts Share Practical Tips to Protect Eyes from Excessive Screen Time

The study also highlights that coffee’s health effects are likely driven by more than caffeine alone. Decaffeinated coffee has also been linked to improvements in learning and memory, indicating that other components, including polyphenols, may play a significant role.

Recent research has suggested that moderate consumption of caffeinated coffee may also reduce anxiety, improve attention and vigilance, and lower levels of inflammation.

Scientists caution that while the findings are promising, more research is needed to determine how significant the NR4A1 pathway is in humans and how it interacts with other biological systems.

Still, the discovery offers an important step toward understanding why coffee remains one of the most widely studied beverages in nutrition science. It also reinforces the idea that compounds found in everyday foods and drinks can play a meaningful role in supporting long-term health and resilience as people age.

Continue Reading

Health

Study Finds Rise in 11 Cancers Among Younger Adults in England

Published

on

A major study has found that rates of 11 types of cancer are increasing among younger adults in England, raising fresh concerns among researchers about factors driving the trend.

The study, conducted by the Institute of Cancer Research and Imperial College London, examined cancer diagnoses between 2001 and 2019 in adults aged 20 to 49. It identified rising incidence in a range of cancers, including breast, colorectal, pancreatic and kidney cancers.

The full list includes breast, colorectal, pancreatic, kidney, liver, gallbladder, thyroid, ovarian and endometrial cancers, as well as oral cancer and multiple myeloma, a form of blood cancer.

Researchers noted that for most of these cancers, rates have also increased among older adults, where cancer remains far more common. This suggests that some shared risk factors may be affecting multiple age groups.

Two cancers, however, stood out. Rates of colorectal and ovarian cancer rose only among younger adults, pointing to possible age-specific causes that are not yet fully understood.

Scientists examined a range of established cancer risk factors, including smoking, alcohol consumption, diet, physical activity and body weight. While these factors are known to contribute significantly to cancer risk, they do not appear to fully explain the recent rise in cases among younger people.

In fact, many of these traditional risk factors have either remained stable or improved over recent decades. Smoking rates have declined, alcohol consumption has generally fallen or levelled off, physical inactivity has decreased, and intake of red and processed meat has dropped.

Obesity was the notable exception. Rates of obesity have risen steadily across all adult age groups and remain a significant contributor to cancer risk. Even so, researchers found that obesity alone could not account for the broader increase in cancer diagnoses among younger adults.

See also  Europe Gears Up for Marathon Season as Runners Take to the Streets

This was particularly true for cancers commonly associated with excess body weight, such as bowel, kidney, pancreatic, liver, gallbladder and endometrial cancers. While rising obesity may be playing a role, it does not fully explain the trend.

The findings suggest that other factors may be contributing. Researchers say further investigation is urgently needed into possible causes, including environmental exposures, changes in diet or lifestyle during childhood, and other early-life influences.

They also pointed to the possibility that improved diagnostic tools, increased screening and greater public awareness may be leading to more cases being detected.

Public health experts say the study highlights the need for continued prevention efforts, particularly in tackling smoking and obesity, which remain more common in disadvantaged communities. As researchers work to better understand the causes, the rise in cancer among younger adults is likely to remain an important area of focus for health authorities.

Continue Reading

Trending